Primary alkaline battery containing bismuth metal oxide
    5.
    发明申请
    Primary alkaline battery containing bismuth metal oxide 有权
    一次碱性电池含有铋金属氧化物

    公开(公告)号:US20050058902A1

    公开(公告)日:2005-03-17

    申请号:US10716358

    申请日:2003-11-17

    摘要: A primary battery includes a cathode having an oxide containing one or more metals and pentavalent bismuth, an anode, a separator between the cathode and the anode, and an alkaline electrolyte. The metal(s) can be an alkali metal, an alkaline earth metal, a transition metal, and/or a main group metal. The separator can be ion-selective or capable of substantially preventing soluble bismuth ionic species from diffusing from the cathode to the anode.

    摘要翻译: 一次电池包括具有含有一种或多种金属和五价铋的氧化物的阴极,阳极,阴极和阳极之间的隔板以及碱性电解质。 金属可以是碱金属,碱土金属,过渡金属和/或主族金属。 分离器可以是离子选择性的或能够基本上防止可溶性铋离子物质从阴极扩散到阳极。

    Medical implant materials containing immobilized transglutaminase
    7.
    发明授权
    Medical implant materials containing immobilized transglutaminase 失效
    含有固定化转谷氨酰胺酶的医疗植入材料

    公开(公告)号:US07718168B2

    公开(公告)日:2010-05-18

    申请号:US10276230

    申请日:2001-05-02

    CPC分类号: A61L27/227

    摘要: The present invention provides a medical implant material comprising mammalian transglutaminase and a polymer, wherein the transglutaminase is provided in the absence of free divalent metal ions and wherein the polymer is associated with the transglutaminase binding protein. Preferably, the transglutaminase is a tissue transglutaminase, which is coated on, impregnated into or covalently linked to the polymer. The polymer may be naturally occuring or synthetic, and may be biodegradable or non-biodegradable. The medical implant material may further comprise a reinforcing agent and/or one or more additional polymers. The invention further provides the use of a mammalian transglutaminase in a method for improving the biocompatibility of a medical implant material, the method comprising the steps of (i) providing a medical implant material comprising a polymer associated with a binding protein for binding the transglutaminase, and (ii) treating said material with a mammalian transglutaminase.

    摘要翻译: 本发明提供包含哺乳动物转谷氨酰胺酶和聚合物的医学植入材料,其中在不存在游离二价金属离子的情况下提供转谷氨酰胺酶,并且其中所述聚合物与转谷氨酰胺酶结合蛋白相关联。 优选地,转谷氨酰胺酶是组织转谷氨酰胺酶,其被涂覆,浸渍或共价连接到聚合物上。 聚合物可以是天然存在的或合成的,并且可以是可生物降解的或不可生物降解的。 医疗植入材料还可以包含增强剂和/或一种或多种另外的聚合物。 本发明进一步提供哺乳动物转谷氨酰胺酶在改善医用植入材料的生物相容性的方法中的用途,所述方法包括以下步骤:(i)提供包含与结合蛋白质结合的聚合物的医用植入材料,所述聚合物与转谷氨酰胺酶结合, 和(ii)用哺乳动物转谷氨酰胺酶处理所述物质。

    Addition polymerization in a homogeneous reaction mixture
    10.
    发明授权
    Addition polymerization in a homogeneous reaction mixture 失效
    在均相反应混合物中加成聚合

    公开(公告)号:US06593439B1

    公开(公告)日:2003-07-15

    申请号:US09719987

    申请日:2001-03-06

    IPC分类号: C08F1820

    CPC分类号: C08F2/06 Y02P20/544

    摘要: A method of producing a polymer comprises the steps of forming a heterogeneous reaction mixture comprising at least one addition polymerizable monomer, a supercritical fluid, and a stabilizer, wherein the stabilizer comprises a chain which is soluble in the supercritical fluid and functional end-group which is not polymerizable by a free-radical mechanism, and polymerizing said at least one monomer in the reaction mixture. In a preferred system for polymerizing acrylic monomers, the fluid comprises supercritical carbon dioxide and the stabilizer comprises an acid-functionalized perfluoropolyether.

    摘要翻译: 制备聚合物的方法包括以下步骤:形成包含至少一种可加成聚合单体,超临界流体和稳定剂的非均相反应混合物,其中稳定剂包括可溶于超临界流体和功能性末端基团的链, 不能通过自由基机理聚合,并且在反应混合物中聚合所述至少一种单体。 在用于聚合丙烯酸单体的优选体系中,流体包含超临界二氧化碳,并且稳定剂包含酸官能化的全氟聚醚。